Xuan Cao

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Capillary Electrophoresis

Epithelial Mesenchymal Transition

Cell Proliferation

Top Venues

Cell death & disease

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hui Xu, Ming Tan, Guo-Qing Hou, Ya-Zhou Sang, Li Lin, Xiao-Cai Gan, Xuan Cao, An-Dong Liu
Blockade of DDR1/PYK2/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer. Cell death & disease 14 (12) (2023)
An-Dong Liu, Jie Zhou, Xiao-Yang Bi, Guo-Qing Hou, Shawn Shun-Cheng Li, Qing Chen, Hui Xu, Xuan Cao
Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma. Clinical and translational medicine 11 (3) (2022)
Lin Xu, Xinge Zhang, Yue Xin, Jie Ma, Chenyan Yang, Xi Zhang, Guoqing Hou, Xiaocheng Charlie Dong, Zhaoli Sun, Xiwen Xiong, Xuan Cao
Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway. Cell death & disease 12 (7) (2021)
Xi Zhang, Hui Xu, Xiaoyang Bi, Guoqing Hou, Andong Liu, Youyun Zhao, Guoping Wang, Xuan Cao
Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways. Cell death & disease 12 (10) (2021)